PMID- 28031137
OWN - NLM
STAT- MEDLINE
DCOM- 20180917
LR  - 20181202
IS  - 1540-9740 (Print)
IS  - 1540-9740 (Linking)
VI  - 14
IP  - 6
DP  - 2016
TI  - Voriconazole-Induced Subacute Cutaneous Lupus Erythematosus in an Adult With 
      Aspergillosis.
PG  - 461-463
AB  - A 59-year-old man was treated with voriconazole for chronic invasive 
      aspergillosis and who subsequently developed subacute cutaneous lupus 
      erythematosus (SCLE). The patient presented with a 6-week history of multiple 
      erythematous papulosquamous lesions on his chest, upper and lower extremities, 
      and back (Figure 1). They were nonpruritic and nonpainful. He was afebrile and 
      otherwise well. He had no history of extensive sun exposure prior to the 
      appearance of the eruption. He had been taking voriconazole for about 3 months 
      prior to the onset of lesions. He denied any family history of connective tissue 
      disease.
FAU - Ezra, Navid
AU  - Ezra N
AD  - Department of Dermatology, Indiana University School of Medicine, Indianapolis, 
      IN; navid.ezra@gmail.com.
FAU - Jourabchi, Natanel
AU  - Jourabchi N
AD  - Department of Dermatology, Johns Hopkins University School of Medicine, 
      Baltimore, MD.
FAU - Mousdicas, Nico
AU  - Mousdicas N
AD  - Department of Dermatology, Indiana University School of Medicine, Indianapolis, 
      IN.
LA  - eng
PT  - Case Reports
DEP - 20161201
PL  - United States
TA  - Skinmed
JT  - Skinmed
JID - 101168327
RN  - 0 (Antifungal Agents)
RN  - JFU09I87TR (Voriconazole)
SB  - IM
MH  - Antifungal Agents/*adverse effects
MH  - Aspergillosis/*drug therapy
MH  - Chronic Disease
MH  - Humans
MH  - Lupus Erythematosus, Cutaneous/*chemically induced
MH  - Male
MH  - Middle Aged
MH  - Voriconazole/*adverse effects
EDAT- 2016/12/30 06:00
MHDA- 2018/09/18 06:00
CRDT- 2016/12/30 06:00
PHST- 2016/12/30 06:00 [entrez]
PHST- 2016/12/30 06:00 [pubmed]
PHST- 2018/09/18 06:00 [medline]
PST - epublish
SO  - Skinmed. 2016 Dec 1;14(6):461-463. eCollection 2016.